UBS Group’s Affimed AFMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-40
| Closed | -$29 | – | 10211 |
|
|
2025
Q1 | $29 | Hold |
40
| – | – | ﹤0.01% | 10056 |
|
|
2024
Q4 | $48 | Buy |
+40
| New | +$112 | ﹤0.01% | 9707 |
|
|
2024
Q3 | – | Sell |
-936
| Closed | -$5.1K | – | 9454 |
|
|
2024
Q2 | $5.1K | Buy |
936
+908
| +3,243% | +$5.1K | ﹤0.01% | 8023 |
|
|
2024
Q1 | $148 | Buy |
+28
| New | +$159 | ﹤0.01% | 8778 |
|
|
2023
Q2 | – | Sell |
-4,707
| Closed | -$35.1K | – | 8834 |
|
|
2023
Q1 | $35.1K | Buy |
4,707
+1,398
| +42% | +$14K | ﹤0.01% | 6687 |
|
|
2022
Q4 | $41K | Buy |
+3,309
| New | +$58.1K | ﹤0.01% | 6953 |
|
|
2022
Q2 | – | Sell |
-4,486
| Closed | -$196K | – | 10248 |
|
|
2022
Q1 | $196K | Sell |
4,486
-5
| -0.1% | -$217 | ﹤0.01% | 5386 |
|
|
2021
Q4 | $248K | Buy |
+4,491
| New | +$277K | ﹤0.01% | 5500 |
|
|
2021
Q2 | – | Sell |
-1,393
| Closed | -$110K | – | 9343 |
|
|
2021
Q1 | $110K | Buy |
1,393
+750
| +117% | +$48.7K | ﹤0.01% | 5891 |
|
|
2020
Q4 | $37K | Buy |
643
+603
| +1,508% | +$28.4K | ﹤0.01% | 6443 |
|
|
2020
Q3 | $1K | Sell |
40
-1,709
| -98% | -$64.7K | ﹤0.01% | 7757 |
|
|
2020
Q2 | $81K | Sell |
1,749
-1,558
| -47% | -$43.4K | ﹤0.01% | 5467 |
|
|
2020
Q1 | $53K | Sell |
3,307
-5,284
| -62% | -$126K | ﹤0.01% | 5786 |
|
|
2019
Q4 | $235K | Buy |
8,591
+2,849
| +50% | +$76.2K | ﹤0.01% | 5490 |
|
|
2019
Q3 | $169K | Buy |
5,742
+4,616
| +410% | +$137K | ﹤0.01% | 5374 |
|
|
2019
Q2 | $32K | Buy |
1,126
+986
| +704% | +$33.2K | ﹤0.01% | 6279 |
|
|
2019
Q1 | $6K | Buy |
140
+100
| +250% | +$3.6K | ﹤0.01% | 7065 |
|
|
2018
Q4 | $1K | Sell |
40
-751
| -95% | -$27.9K | ﹤0.01% | 7873 |
|
|
2018
Q3 | $34K | Sell |
791
-4,366
| -85% | -$124K | ﹤0.01% | 6443 |
|
|
2018
Q2 | $85K | Buy |
5,157
+5,077
| +6,346% | +$107K | ﹤0.01% | 5566 |
|
|
2018
Q1 | $2K | Buy |
80
+40
| +100% | +$755 | ﹤0.01% | 7515 |
|
|
2017
Q4 | $1K | Sell |
40
-166
| -81% | -$3.15K | ﹤0.01% | 7689 |
|
|
2017
Q3 | $5K | Sell |
206
-80
| -28% | -$1.73K | ﹤0.01% | 7202 |
|
|
2017
Q2 | $6K | Buy |
+286
| New | +$6.35K | ﹤0.01% | 7028 |
|
|
2017
Q1 | – | Sell |
-275
| Closed | -$5K | – | 7595 |
|
|
2016
Q4 | $5K | Sell |
275
-32
| -10% | -$690 | ﹤0.01% | 7229 |
|
|
2016
Q3 | $9K | Buy |
307
+25
| +9% | +$701 | ﹤0.01% | 6830 |
|
|
2016
Q2 | $7K | Buy |
282
+82
| +41% | +$3K | ﹤0.01% | 6955 |
|
|
2016
Q1 | $7K | Sell |
200
-213
| -52% | -$8.03K | ﹤0.01% | 6833 |
|
|
2015
Q4 | $29K | Buy |
413
+178
| +76% | +$12.1K | ﹤0.01% | 6355 |
|
|
2015
Q3 | $14K | Buy |
235
+141
| +150% | +$17.5K | ﹤0.01% | 7003 |
|
|
2015
Q2 | $13K | Buy |
94
+37
| +65% | +$3.55K | ﹤0.01% | 7242 |
|
|
2015
Q1 | $4K | Buy |
+57
| New | +$3.52K | ﹤0.01% | 8194 |
|
Other funds holding AFMD
UBS Group's AFMD Position: Q2 2025 in Review
UBS Group sold out of Affimed (AFMD) in Q2 2025, closing a stake of 40 shares — an estimated $29 sold.
UBS Group first reported a position in AFMD in Q1 2015 and held it in 32 quarters. The position peaked at $248K in Q4 2021. 3 funds tracked by Wall St. Rank hold AFMD as of Q2 2025.
- UBS Group reported no remaining Affimed position as of Q2 2025 after selling out during the quarter.
- UBS Group sold 40 Affimed shares in Q2 2025, an estimated $29.
- UBS Group first reported a position in Affimed in Q1 2015 and held it in 32 quarters.
- UBS Group's Affimed position peaked at $248K in Q4 2021.
- 3 funds tracked by Wall St. Rank held Affimed as of Q2 2025.
Based on UBS Group's 13F filing for Q2 2025, filed 14 Aug 2025.